Skip to main content
64°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
Contact Us
Subscribe
News
East Greenwich Pendulum
Kent County Daily Times
Narragansett Times
NK Standard-Times
Sports
Features
Special Sections
Local Guide
Local Events
Markets & Stocks
Weather
Classifieds
Place ad
Legal Notices
Place Kent Legal
Place SRI Class Legal
Search SRI Legals
Search Kent Legals
Obituaries
Subscribe
E-Edition
Community Choice
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Homology Medicines Inc
(NQ:
FIXX
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Mar 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Homology Medicines Inc
< Previous
1
2
3
Next >
FIXX Stock Earnings: Homology Medicines Beats EPS for Q4 2023
March 15, 2024
FIXX stock results show that Homology Medicines beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
January 01, 2024
Via
Benzinga
Gold Gains 1%; Williams-Sonoma Posts Upbeat Earnings
November 16, 2023
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling over 100 points on Thursday. The Dow traded down 0.39% to 34,853.42 while the NASDAQ fell 0.11% to 14,087.96. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Children's Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
November 16, 2023
Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.
Via
Benzinga
The Latest Analyst Ratings for Homology Medicines
July 28, 2023
Via
Benzinga
Homology Medicines Provides Update From Gene Therapy Trials
January 05, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
November 16, 2023
Via
Benzinga
Crude Oil Down 4%; Walmart Shares Fall After Q3 Results
November 16, 2023
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Thursday. The Dow traded down 0.40% to 34,850.49 while the NASDAQ fell 0.35% to 14,055.15. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Is Rare Disease Focused Homology Medicines Stock Trading Lower Today?
November 16, 2023
Q32 Bio Inc and Homology Medicines Inc (NASDAQ: FIXX) have entered into a definitive merger agreement to combine the companies in
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
November 15, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
July 28, 2023
Via
Benzinga
4 Analysts Have This to Say About Homology Medicines
August 31, 2022
Analysts have provided the following ratings for Homology Medicines (NASDAQ:FIXX) within the last quarter:
Via
Benzinga
Homology Medicines Pauses Enrollment For Rare Inherited Disorder Study
August 16, 2022
Via
Benzinga
Why Avantor Shares Are Trading Lower By 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 28, 2023
Gainers Unique Fabricating, Inc. (NYSE: UFAB) shares jumped 113% to $0.4605 after gaining 12% on Thursday.
Via
Benzinga
What's Going On With Homology Medicines Stock Today?
July 28, 2023
Homology Medicines Inc (NASDAQ: FIXX) announced initial data from the first dose cohort in the pheEDIT Phase 1 dose-escalation trial evaluating gene editing candidate HMI-103 in adults with
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
July 28, 2023
Via
Benzinga
Homology Medicines: Q2 Earnings Insights
August 15, 2022
Homology Medicines (NASDAQ:FIXX) reported its Q2 earnings results on Monday, August 15, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 28, 2023
July 28, 2023
Via
Benzinga
Why Coursera Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
July 28, 2023
Gainers Unique Fabricating, Inc. (NASDAQ: UFAB) shares surged 62.6% to $0.3512 in pre-market trading after gaining 12% on Thursday.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
July 28, 2023
We're starting off the day with a breakdown of all the biggest pre-market stock movers traders need to know about on Friday!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
July 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
March 21, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 04, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 12, 2022
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
October 26, 2022
It's time to start off the day with a breakdown of the biggest pre-market stock movers for Wednesday morning and the latest news!
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's Pre-Market Session
August 29, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 15, 2022
Via
Benzinga
Homology Medicines Announces Preclinical Gene Therapy Candidate For Genetic Storage Disorder
August 12, 2022
Homology Medicines Inc (NASDAQ: FIXX) announced the details of HMI-204, its optimized, in vivo, one-time gene therapy candidate for metachromatic leukodystrophy (MLD).
Via
Benzinga
Why Plug Power Is Trading Higher By Around 14%, Here Are 73 Stocks Moving In Wednesday's Mid-Day Session
August 10, 2022
Gainers BioAtla, Inc. (NASDAQ: BCAB) gained 50.1% to $5.42 following Q2 results. Euro Tech Holdings Company Limited (NASDAQ: CLWT) surged 39.5% to $2.0380.
Via
Benzinga
Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday
August 11, 2022
Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.